SODIUM FUSIDATE 500 MG FOR INTRAVENOUS INFUSION

Active substance: SODIUM FUSIDATE

View full screen / Print PDF » Download PDF ⇩

Transcript
PACKAGE LEAFLET: INFORMATION FOR THE USER
Sodium Fusidate 500 mg for Intravenous Infusion
sodium fusidate
Please read all of this leaflet carefully before you start taking this medicine.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you. Do not pass it on to others. It may harm
them, even if their symptoms are the same as yours.
• If any of the side effects become serious, or you notice any side effects not listed in
this leaflet please tell your doctor or pharmacist.
• In this leaflet Sodium Fusidate 500 mg for Intravenous Infusion will be called sodium
fusidate infusion.
In this leaflet:
1. What sodium fusidate infusion is and what it is used for
2. Before you have sodium fusidate infusion
3. How to use sodium fusidate infusion
4. Possible side effects
5. How to store sodium fusidate infusion
6. Further information
1. WHAT SODIUM FUSIDATE INFUSION IS AND WHAT IT IS USED FOR
This medicine contains sodium fusidate. It is a type of antibiotic.
Sodium fusidate infusion works by killing germs (bacteria) that cause infections.
Sodium fusidate infusion is used to treat infections such as:
• Infections of the skin and wounds
• Infections of the blood such as septicaemia
• Infections of the bone and heart tissue
• Infections of the lungs such as pneumonia
• Infections connected with the condition cystic fibrosis.
2. BEFORE YOU HAVE SODIUM FUSIDATE INFUSION
Do not have sodium fusidate infusion
• If you are allergic (hypersensitive) to fusidic acid or its salts.
• If you are allergic (hypersensitive) to any of the other ingredients in your medicine.
You can find a list of these ingredients in section 6 of this leaflet.
Take special care with sodium fusidate infusion
Before you have sodium fusidate infusion, tell your doctor:
• If you are taking statins (medicines to lower blood cholesterol).
• If you have problems with your liver.
• If you have recently been jaundiced.
When you are having sodium fusidate infusion your doctor may take regular blood tests in
patients on high doses, with liver or bile problems, taking the medicine for a long time or
taking other medicines that affect the liver.

If you are concerned that your treatment is not as effective as it should be, tell your doctor.
As with any antibiotic treatment, long term or repeated use may increase the risk of
developing antibiotic resistance.
Taking other medicines
Please tell your doctor or pharmacist if you are taking, or have recently taken any other
medicines. This includes any medicines which you have bought without a prescription.
• Do not take statins (medicines to lower blood cholesterol) while using this medicine.
You must tell your doctor or pharmacist if you are taking any of the following medicines:
• Other antibiotics, such as lincomycin and rifampicin.
• Oral anti-coagulants (medicines to "thin" your blood). You may be likely to bleed
more easily. Your doctor may need to change your dose.
• Medicines to lower blood cholesterol, such as statins. This may lead to muscle
weakness, tenderness or pain. Also see section 4 of this leaflet.
• Ritonavir or saquinavir, medicines used to treat HIV.
• Ciclosporin. This medicine is used to reduce the body's immune reactions.
Pregnancy and breast-feeding
Please ask your doctor or pharmacist for advice before having sodium fusidate infusion:
• If you are pregnant, or think you are pregnant
• If you are breast-feeding.
Tell your doctor if you become pregnant while having this medicine.
Driving and using machines
Usually your medicine will have very little effect on your ability to drive or use machines.
Check with your doctor if you feel any side effect that may stop you from driving or using
machines.
Important information about some of the ingredients of sodium fusidate infusion
Sodium fusidate infusion contains:
• Sodium. Each reconstituted vial contains 73 milligrams (mg) sodium. You should
take this into consideration if you are on a controlled sodium diet.
Please ask your doctor if you are worried about any of the ingredients in this medicine.
3. HOW TO USE SODIUM FUSIDATE INFUSION
Sodium fusidate infusion will be given to you into your vein by a doctor or nurse.
How much sodium fusidate infusion to have
Your doctor will prescribe the right dose for you.
If you have received more sodium fusidate infusion than you should
Your doctor or nurse will give you this medicine. If you think you may have been given too
much, tell your doctor or nurse straight away.
If you have missed a dose of sodium fusidate infusion
Your doctor or nurse will give you this medicine. If you think that you have missed a dose
then tell your doctor or nurse.
If you have any further questions about using this medicine, please ask your doctor or
pharmacist.

4. POSSIBLE SIDE EFFECTS
Like all medicines, sodium fusidate infusion can cause side effects, although not everybody
gets them.
Approximately 3 out of 10 people may experience side effects with sodium fusidate infusion,
but many of these are where the medicine is given into the vein.
Serious side effects:
Rare (affects less than 1 in 1,000 people): allergic reaction. You must get urgent medical
help if you have any of the following symptoms:
• You have difficulty breathing
• Your face or throat swell
• Your skin develops a severe rash.
Number of people affected not known: You must get urgent medical help if you have
any of the following symptoms. You may be developing a condition called
rhabdomyolysis:
• You develop muscle weakness
• You develop muscle pain
• You develop muscle tenderness.
Common: affects less than 1 in 10 people: problems with your liver.
You should tell your doctor straight away if you have the following symptoms:
• Your skin or the whites of your eyes appear yellow.
Number of people affected not known: problems with your kidneys.
You should tell your doctor straight away if you have the following symptoms:
• You are not passing water.
Number of people affected not known: the level of some cells in your blood may change.
You should tell your doctor straight away if you have any of the following symptoms:
• You develop any unexplained bruising or bleeding
• You develop persistent or repeated mouth ulcers, sore throats or other
infections.
Other possible side effects:
Common (affect less than 1 in 10 people):
Pain or inflammation of the vein where sodium fusidate infusion is given, dizziness,
drowsiness.
Uncommon (affect less than 1 in 100 people):
Headache, rash, itchy rash, itching, loss of appetite, feeling tired, weak or unwell.
Number of people affected not known:
Pale stools
Dark urine
Upper right hand side stomach pain.

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any
possible side effects not listed in this leaflet. You can also report side effects directly via the
Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this
medicine.
5. HOW TO STORE SODIUM FUSIDATE INFUSION




Keep out of the reach and the sight of children.
Do not use sodium fusidate infusion after the expiry date on the carton. The expiry
date is the last day of that month.
Store in a refrigerator (2ºC to 8ºC)

6. FURTHER INFORMATION
What sodium fusidate infusion contains
• The active ingredient is sodium fusidate. A vial of powder contains 500 mg of sodium
fusidate.
• The other ingredients are citric acid, disodium edetate, disodium hydrogen phosphate
and water for injections.
You can find important information about some of the ingredients in your medicine near the
end of section 2 of this leaflet.
What sodium fusidate infusion looks like and contents of the pack
Sodium fusidate infusion comes in packs of 2 vials. One vial contains sodium fusidate
(powder) and the other vial the solution for the infusion.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder:
Essential Pharma Ltd, 7 Egham Business
Village, Crabtree Road, Egham, Surrey,
TW20 8RB, UK.
Manufacturer:
FAMAR Health Care Services Madrid S.A.U
Avda, De Leganes 62
28923 Alcorcon, Madrid
Spain
This leaflet was last revised in October 2014

PLEASE TEAR ALONG THE PERFORATIONS AND RETAIN THIS PORTION
BEFORE GIVING THE REMAINING LEAFLET TO THE PATIENT.
FOR MEDICAL OR HEALTHCARE PROFESSIONALS ONLY
Sodium Fusidate 500 mg for Intravenous Infusion
Sodium Fusidate Ph.Eur. 500 mg (equivalent to 480 mg fusidic acid) contained in one vial.
(The second vial contains buffer solution).
Powder for reconstitution and use as an intravenous infusion.
The vial of 10 ml sterile phosphate-citrate buffer solution (pH 7.4 - 7.6) contains disodium
hydrogen phosphate, citric acid, disodium edetate and water for injections. (When
reconstituted with powder vial contains 3.1 mMol sodium and 1.1 mMol phosphate).
Shelf-life and storage conditions: The sodium fusidate dry powder is stable for 1 year when
stored in a refrigerator (2ºC - 8ºC). After the sodium fusidate dry powder is dissolved in the
buffer solution provided and added to 500 ml of infusion fluid, the solution should be used
immediately.
When the buffer solution is transferred to the powder vial, this vial should be regarded as a
unit dose. The required amount of solution should be used once only and any unused portion
discarded.
Recommended procedure for reconstitution and administration:
To reconstitute, dissolve the contents of one vial containing 500 mg sodium fusidate powder
(equivalent to 480 mg of fusidic acid) in the 10 ml buffer provided.
For adults weighing more than 50 kg: Add the 10 ml fusidate/buffer solution to 500 ml of
infusion fluid.
For children and adults weighing less than 50 kg: Add the 10 ml fusidate/buffer solution to
500 ml of infusion fluid. Each dose corresponds to 6-7 ml of the resulting solution per kg
bodyweight.
The diluted fluid should be infused via a central venous line over 2 hours. If a superficial vein
is employed a more prolonged period of at least 6 hours is advisable.
This product should be administered intravenously into a wide bore vein with a good blood
flow. Excessive doses may cause venospasm, thrombophlebitis and haemolysis of
erythrocytes. Both oral and intravenous presentations have been given concurrently with
other antibiotics, e.g. cloxacillin, flucloxacillin, ampicillin, methicillin and erythromycin.
If additional antibacterial therapy is to be employed, it is recommended that for parenteral
administration, separate infusion fluids be used.
This product should not be infused with amino acid solutions or in whole blood.
In vitro compatibility studies of Sodium Fusidate 500 mg for Intravenous Infusion with
commonly used infusion solutions have been carried out.

The results showed that sodium fusidate reconstituted at 50 mg/ml in buffer solution is
physically and chemically compatible with the following infusion solutions (the figure in
parenthesis shows the concentration of sodium fusidate in the final admixture):
Sodium Chloride Intravenous Infusion BP 0.9% (1-2 mg/ml)
Dextrose Intravenous Infusion BP 5% (1-2 mg/ml)
Compound Sodium Lactate Intravenous Infusion ("Ringer-Lactate Solution") (1 mg/ml)
Sodium Lactate Intravenous Infusion BP (1 mg/ml)
Sodium Chloride (0.18%) and Dextrose (4%) Intravenous Infusion BP (1 mg/ml)
Potassium Chloride (0.3%) and Dextrose (5%) Intravenous Infusion BP (1 mg/ml).
Sodium fusidate reconstituted at 50 mg/ml in buffer solution is physically incompatible with
infusion fluids containing 20% or more of dextrose, lipid infusions and peritoneal dialysis
fluids. Precipitation may occur at dilutions which result in a pH of less than 7.4.
Further information can be found in the Summary of Product Characteristics or from:
Essential Pharma Ltd, 7 Egham Business Village, Crabtree Road, Egham, Surrey,
TW20 8RB, UK.

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web4)